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Carotid body tumor resection utilizing a covered stent
graft to enable resection of the tumor en bloc with the
internal carotid artery
Mohammad Alqaim, MD, Ajit S. Puri, MD, DM, Alec E. Vaezi, MD, PhD, and
Andres Schanzer, MD, Worcester, Mass
ABSTRACT
Surgical excision is the primary treatment for carotid body tumors (CBT) and infrequently involves carotid vessels
reconstruction. A CBT that extends distally to the level of the skull base makes surgical reconstruction very challenging.
We report a case of a 30-year-old man who presented with a CBT (Shamblin III) extending to the base of the skull. A
covered stent graft was placed in the internal carotid artery. Subsequently, a successful resection of the tumor with the
arterial wall en bloc was performed, leaving the stent graft exposed as a bridge between the two ends of ICA. (J Vasc Surg
Cases and Innovative Techniques 2019;5:481-4.)
CASE REPORT
A 30-year-old man with a history of seizure disorder presented
with a progressively growing, painless, and pulsatile mass in left
neck of 6 months duration. The patient was asymptomatic and
had no constitutional symptoms of fever, chills, or malaise, and
no evidence of hoarseness. He also denied any personal or family
history of paragangliomas. On physical examination, a 5-cm pul-
satile and nontender mass was present in the left anterolateral
neck. Contralateral neck examination was normal. No cranial
nerve deficits were identified and nasal laryngoscopy demon-
strated normal vocal cord mobility. He underwent a series of
radiologic studies including a computed tomography angio-
gram that showed a 4.6-  6.3-cm mass encasing the common
carotid artery (CCA), internal carotid artery (ICA), external carotid
artery (ECA) and splaying the carotid bifurcation with luminal
narrowing of ICA (Fig 1). Themass was found to extend superiorly
to the level of the skull base. There was no contralateral tumor.
He also underwent an octreotide scan and a 24-hour urine
metanephrine collection. The results of these tests were consis-
tent with a nonfunctional carotid body tumor (CBT). Based on
the presentation and imaging, the patient was diagnosed with
a CBT (Shamblin class III) extending from the carotid bifurcation
to the base of the skull.
Based on the extent of the tumor, a multidisciplinary team
(ENT, vascular surgery, and neurointerventional radiology) was
assembled to plan and execute the CBT resection. The decision
was made to proceed with the balloon occlusion test and a first-
stage embolization of the ECA. Both of these procedures were
performed in the same setting. The balloon occlusion test was
performed because of the team’s concern that, with the distal
tumor extending to the skull base, if a shunt were needed dur-
ing reconstruction of the ICA, it would not be technically
possible. On balloon occlusion testing, the patient immediately
developed contralateral upper extremity paresthesias and
weakness. For the embolization, a microcatheter was used to
select branches of the ECA that were directly feeding the tumor.
These were successfully coil embolized using 2 mm  3 cm
Axium coils (ev3, Irvine, Calif). However, there remained multiple
smaller branches that were not able to be selectively cannu-
lated. A 6 mm  10 mm Amplatzer plug was deployed at the
ECA trunk for total vessel occlusion. Owing to the positive
balloon occlusion test, the decision was made to preserve the
vessel and proceed with placement of a covered stent graft
the following day extending from the left CCA to the left ICA
just above the skull base. We used a standard Seldinger tech-
nique to gain access in the left common femoral artery and a
9F femoral sheath was placed. With the combination of a 5F
Bernstein catheter and a 0.035” guidewire, the left CCA/ICA
was selected. A 6F shuttle guide catheter was then advanced
and positioned 2 cm proximal to the left carotid bifurcation.
The Berenstein catheter was then exchanged for a stiff guide-
wire. Over this wire, a 9 mm  10 cm Gore Viabahn (W. L. Gore
& Associates, Flagstaff, Ariz) stent graft was deployed. After
deployment, the diagnostic catheter was then advanced into
the left CCA for follow-up angiograms of the neck and of the
brain. Given the absence of atherosclerotic plaque, an embolic
protection device was not used. The plan was for the stent graft
to serve as a conduit to provide uninterrupted blood flow to the
distal ICA during resection of the CBT and ICA wall. The patient
was kept on aspirin for the stent graft.
The patient tolerated the first stage well and was then brought
to the operating room 48 hours later for second stage surgical
resection. As a precautionary measure, intraoperative
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neuromonitoring was used. A curvilinear incision was performed
in the anterolateral left neck at the level of the inferior border of
the submandibular gland. Subplatysmal flaps were elevated.
The anterior border of the sternocleidomastoidmuscle was skel-
etonized and retracted laterally. Proximal circumferential con-
trol of the CCA was obtained. Attention was then turned
toward the distal aspect of the tumor. The hypoglossal nerve
was identified and preserved. The tumor was then dissected,
in an antegrade-retrograde fashion, off of the CCA using a com-
bination of sharp dissection between ties and harmonic scalpel.
The tumor was freed from the surrounding structures. The supe-
rior laryngeal nerve was encompassed by the tumor and was
resected. At the level of the carotid bifurcation, the tumor was
invasive into the arterial wall, which required careful resection
of the entire artery wall leaving the covered stent graft visible
(Fig 2). Care was taken not to dislodge the stent graft and to
ensure that the stent graft was not incised. The tumor was
then removed uneventfully and sent for histopathologic exami-
nation (Fig 3). There was minimal blood loss with mild postoper-
ative dysphagia. The patient was discharged home on
postoperative day 3 tolerating a regular diet. A surveillance
computed tomography angiogram of the head and neck
4 weeks after the surgery demonstrated a widely patent stent
graft with no evidence of residual tumor (Fig 4).
DISCUSSION
CBTs are rare neoplasms that originate from neural
crest cells located at the level of carotid bifurcation and
represent the most common type of neck paraganglio-
mas.1 Vascular surgeons are frequently involved in their
management. Tumor resection is the treatment of
choice and radiotherapy is reserved for recurrent tumors
or patients who are poor surgical candidates. The Sham-
blin classification of the CBT is chiefly based on the rela-
tionship of the tumor to the carotid vessels, ICA, and ECA.
A type I tumor is small and easily separated from the
adjacent arterial wall. Type II lesions are larger and
partially encapsulate the vessel. Type III lesions are
densely adherent to and intimately surround the carotid
arteries.2 A traditional surgical approach becomes
increasingly challenging as the Shamblin class increases
and when the tumor encases the CCA/ICA circumferen-
tially. In these cases, any attempt at complete resection
carries a substantial risk of blood loss and cranial nerve
injury. To mitigate the risk of blood loss and to aid in safer
resection, preoperative ECA coil embolization has
become a preferred strategy by many.3,4 Another tech-
nique reported has involved placing a covered stent in
the ECA to cover the primary feeding branches to the
Fig 1. Axial computed tomography angiography showing
an avidly enhancing mass encasing and splaying the
internal carotid artery (ICA) and external carotid artery
(ECA).
Fig 2. Intraoperative image of the common carotid artery
(CCA)-internal carotid artery (ICA) with a thin vascular wall
and a visible stent graft.
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tumor.5 Although ECA sacrifice or embolization is gener-
ally well-tolerated, ICA ligation is associated with a 25%
risk of stroke.6,7 Traditionally, in cases where carotid artery
resection is required, cerebral revascularization is
achieved with a GSV or prosthetic interposition graft.8,9
However, for tumors that extend to the level of skull
base, obtaining distal control is difficult, making surgical
revascularization a high-risk option. This risk becomes
more significant if a shunt is required owing to the addi-
tional distal ICA length that is necessary to safely secure a
shunt during revascularization.
Based on the radiologic evidence of complete ICA
encasement by tumor, it was clear that this patient
would require resection of the ICA with the tumor.
Whenever ICA resection or need for occlusion of the
ICA to facilitate reconstruction is being considered, we
use a balloon occlusion test. We routinely performed
this test to assess the collateral circulation to aid in the
decision-making process when carotid artery ligation
versus reconstruction is in question. Our patient demon-
strated contralateral upper extremity numbness almost
immediately after balloon occlusion. At the time, his sys-
tolic blood pressure was 135 mm Hg and his diastolic
blood pressure was 80 mm Hg. Given his symptoms,
we suspect that he may have had insufficient intracranial
collateral circulation or vasodilatory reserve to provide
adequate cerebral blood flow at the time of occlusion.
Unfortunately, there is no standardized way to quantify
inadequate blood flow during a balloon occlusion test
and the results of the test are entirely based on the clin-
ical symptoms.
Given the preoperative positive balloon occlusion test,
any carotid resection would require preservation of ante-
grade blood flow through the ICA. To achieve this goal
during traditional surgical revascularization would
require shunt placement during the reconstruction. The
multidisciplinary team believed that safe placement of
a shunt was not technically possible given the distal
extent of the tumor to the base of the skull. Therefore,
the decision was made to place a covered stent graft
to serve as a bridge between the two ends of carotid ar-
tery below and above the tumor; this stent graft bridge
would preserve continuous antegrade blood flow while
the tumor and wall of the ICA were resected. To our
knowledge, this is the first report documenting the use
of a stent graft in the ICA to facilitate CBT resection en
bloc with the wall of the ICA and leaving the stent graft
exposed as a bridge between normal artery below and
normal artery above. When using this technique, great
care should be taken not to dislodge the stent. Careful
attention to ensuring an adequate proximal and distal
seal length is critical to mitigate this risk. We intentionally
chose to use a 10-cm length stent graft to ensure that we
could deploy it in normal, uninvolved, carotid artery with
a minimum of 2 cm above and 2 cm below the tumor.
Protective ICA stenting in the management of head
and neck cancer was first reported by Nussbaum et al10
Fig 4. Multislice spiral computed tomography angiog-
raphy with three-dimensional reconstruction at 1 month
demonstrating adequate positioning of the stent.
Fig 3. Gross specimen of the resected carotid body tumor
(CBT).
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in 2000. They reported a single case of bare metal stent
placement 1 month before the planned resection of the
neck malignancy involving the ICA. This allowed for a
neoendothelium formation and subsequent resection
of the entire arterial wall. However, the first use of preop-
erative ICA/CCA covered stenting was reported by
Markiewicz et al11 in a case series of five patients who sub-
sequently underwent successful subadventitial resection
of the head and neck tumors without needing revascu-
larization. Although surgical peel, or subadventitial resec-
tion, might be sufficient in some patients, in cases with
circumferential involvement or frank invasion of the ICA
is present, as in our patient’s case, a complete resection
of the entire arterial wall is required.
CONCLUSIONS
We report a case of a 30-year-old man who presented
with a CBT (Shamblin III) extending to the base of the
skull. A covered stent graft was placed in the ICA preop-
eratively that allowed for a complete resection of the tu-
mor with the arterial wall en bloc while maintaining an
uninterrupted blood flow to the distal ICA. Surgical
resection and arterial wall reconstruction with vein re-
mains the gold standard treatment, but in cases where
distal control of the vessel is not obtainable, a placement
of a covered stent greatly helps in resection of the tumor.
No data yet exist on the long-term patency of covered
stents in the carotid system. The natural size mismatch
between the CCA and the ICA often leads to significant
stent oversizing in the ICA. Although purpose-built ca-
rotid artery bare metal stents are made in tapered con-
figurations, currently, there are no tapered covered
stents that are commercially available. Therefore, we
deliberately chose to use a self-expanding stent graft
because it has the property of self-tapering and, gener-
ally, will contour to the inner lumen of the carotid artery.
Given the oversizing, long-term surveillance is imperative
to evaluate for any subsequent restenosis owing to fabric
infolding. This patient requires life-long surveillance
duplex imaging follow-up.
The authors would like to acknowledge the patient in
this case report for providing consent to publish.
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